Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Odense
Clinical trial register · Denmark

Clinical Trials in Odense, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Denmark and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2472 matching records held by the registry are in this view. Synced 18 Nov 2026, 03:19 UTC
2472
Studies in scope
all four open statuses
1403
Recruiting now
open to new participants
448
Lead sponsors
across recruiting studies
Top sites
Aarhus 1 Copenhagen 1 Odense 1
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Odense University Hospital80 University of Southern Denmark22 Copenhagen University Hospital, Rigshospitalet22 University of Aarhus20 Merck Sharp & Dohme LLC17 AstraZeneca14 Janssen Research & Development, LLC11 AbbVie9 Bristol-Myers Squibb7 Stichting Hemato-Oncologie voor Volwassenen Nederland6 Bayer6 Genmab6 Celgene5 Eli Lilly and Company5 Sanofi5 Zealand University Hospital5 Aalborg University Hospital5 Aarhus University Hospital Skejby5 Aarhus University Hospital5 Pfizer4 Medtronic4 Takeda3 Oslo University Hospital3 Juno Therapeutics, Inc., a Bristol-Myers Squibb Company3 Blueprint Medicines Corporation3 Jørgen Bjerggaard Jensen2 Abbott Medical Devices2 Amsterdam UMC, location VUmc2 Kardigan, Inc.2 InnoCon Medical2 Incyte Corporation2 Mats Heyman2 University Hospital Muenster2 Gitte Fredberg Persson MD PhD2 Cytokinetics2 Boston Scientific Corporation2 Nordic Lymphoma Group2 Boehringer Ingelheim2 Uppsala University2 Stemline Therapeutics, Inc.2 Alnylam Pharmaceuticals2 Region of Southern Denmark2 Vejle Hospital2 UMC Utrecht2 Gustave Roussy, Cancer Campus, Grand Paris2 Norwegian University of Science and Technology2 Danish Breast Cancer Cooperative Group2 Copenhagen University Hospital at Herlev2 Marianne Andersen2 Susanne Dam Nielsen, MD, DMSc2 Mirati Therapeutics Inc.2 Biohaven Therapeutics Ltd.2 Karolinska Institutet2 Thomas Engstrom2 Aleksander Krag1 Alexion Pharmaceuticals, Inc.1 Geron Corporation1 pharmaand GmbH1 Celcuity Inc1 Rasmus Bo Hasselbalch1 Institut de Recherches Internationales Servier1 Jesper Kjaergaard1 Loxo Oncology, Inc.1 Medtronic - MITG1 Region Skane1 Change Accelerator in Respiratory Care1 Helsinki University Central Hospital1 Christian Hassager1 Angitia Incorporated Limited1 Christoffer Johansen1 RhoVac APS1 Ole Lander Svendsen1 Per Løgstrup Poulsen1 Haukeland University Hospital1 Ditte Hansen1 Dimerix Bioscience Pty Ltd1 Contura1 Regeneron Pharmaceuticals1 Kyowa Kirin Pharmaceutical Development Ltd1 Kolding Sygehus1 Vastra Gotaland Region1 Inge Marie Svane1 Genentech, Inc.1 Niels Fristrup1 Morten Steen Kvistholm Jensen1 Maja Thiele1 Daiichi Sankyo1 Region Zealand1 Calluna Pharma AS1 Peter Martin Hansen1 Viatris Innovation GmbH1 Jon Unosson1 Nuvalent Inc.1 University Medical Center Groningen1 Rikke Sorensen1 Immunovant Sciences GmbH1 Josefine Gradman1 Xentria, Inc.1 Region Örebro County1 Rezolute1 Kirsten Grønbæk1 Princess Maxima Center for Pediatric Oncology1 Olfred Hansen1 Lars Peter Riber1 Sanofi Pasteur, a Sanofi Company1 Herlev and Gentofte Hospital1 Servier Bio-Innovation LLC1 Kartos Therapeutics, Inc.1 Holbaek Sygehus1 IO Biotech1 Danish Headache Center1 Thomas Decker Christensen1 Thomas Lund1 Phillip Freeman1 Institut universitaire de cardiologie et de pneumologie de Québec, University Laval1 UCB Biopharma SRL1 Janssen-Cilag Ltd.1 Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital1 Ida Bruun Kristensen1 University of Birmingham1 Center for Clinical Research and Prevention1 Anne Louise Tølbøll Sørensen1 Stichting European Myeloma Network1 SecuraBio1 Sahlgrenska University Hospital1 Christian von Buchwald1 Sven Löffeler1 Ole Frobert, MD, PhD1 European Myeloma Network B.V.1 Eisai Inc.1 Erasme University Hospital1 Olof Akre1 Ulrik Lassen1 Henrik Nielsen1 St. Olavs Hospital1 Vitestro B.V.1 Mikkel Herly1 Bo Gregers Winkel1 European Society of Cardiology1 CHDI Foundation, Inc.1 Michael Bau Mortensen1 Amgen1 North Estonia Medical Centre1 Herlev Hospital1 Shanghai MicroPort Medical (Group) Co., Ltd.1 BioNTech SE1 argenx1 Aragon Pharmaceuticals, Inc.1 European Organisation for Research and Treatment of Cancer - EORTC1 Alentis Therapeutics AG1 Claus Lindbjerg Andersen1 Revolution Medicines, Inc.1 BeOne Medicines1 Marianne Christina Klose1 Jazz Pharmaceuticals1 Population Health Research Institute1 Medtronic Cardiovascular1 Tor Biering-Sørensen1 CarThera1 UNEEG Medical A/S1 University Hospital of North Norway1 Kresten Krarup Keller1 Esbjerg Hospital - University Hospital of Southern Denmark1 German CLL Study Group1 Acacia Pharma Ltd1 Clear sponsor filter
Site location
Aarhus1 Copenhagen1 Odense1
All 3 locations
Target enrolment
to

Trials with a site in Odense

1 of 2472 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Denmark
Start
Recruiting
Thomas Decker Christensen
Not applicable
184
Aarhus, Copenhagen, Odense
2022-10-30
Rows per page Showing 1–1 of 1
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Danish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 November 2026. https://priyalifescience.com/clinical-trials-denmark/city/odense

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Denmark and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,472 studies in total at the last sync on 18 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1 of those studies with a site in Odense that also match the filters currently applied.

How many clinical trials are recruiting in Odense?

1 of the 1 studies on this page are recruiting new participants as of the 18 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Odense), 1 studies
PhaseStudiesRecruitingShare
Not applicable11100%

Most active sponsors

Lead sponsors with the most studies (Odense)
Lead sponsorStudiesRecruiting
Thomas Decker Christensen11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.